Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by GUGLIELMO, B. J.
Right arrow Articles by STULBARG, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUGLIELMO, B. J.
Right arrow Articles by STULBARG, M. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Correspondence

Pharmacoklnetics of once-daily versus thrice daily tobramycin in cystic flbrosis patients

B. JOSEPH GUGLIELMO, LORI A. QUAN, and MICHAEL S. STULBARG

You have reached the most complete version of this article accessible without further authentication.
More complete versions are available.
Link to article

Article topics:

  • Microbiology..Vancomycin
  • Microbiology..Staphylococcus
  • Pharmacology..Antibiotics
  • Neuroscience..Central Nervous System

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. Aminimanizani, P. M. Beringer, J. Kang, L. Tsang, R. W. Jelliffe, and B. J. Shapiro
Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis
J. Antimicrob. Chemother., October 1, 2002; 50(4): 553 - 559.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Whitehead, S.P. Conway, C. Etherington, N.A. Caldwell, N. Setchfield, and S. Bogle
Once-daily tobramycin in the treatment of adult patients with cystic fibrosis
Eur. Respir. J., February 1, 2002; 19(2): 303 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
P Vic, S Ategbo, D Turck, M O Husson, V Launay, G A Loeuille, A Sardet, A Deschildre, D Druon, and C Arrouet-Lagande
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
Arch. Dis. Child., June 1, 1998; 78(6): 536 - 539.
[Abstract] [Full Text]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by GUGLIELMO, B. J.
Right arrow Articles by STULBARG, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUGLIELMO, B. J.
Right arrow Articles by STULBARG, M. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?